Fulcrum Therapeutics Inc (FULC)
SG&A Expense Growth
-7.90%
Quarterly · Period ending:
FULC SG&A Expense Growth
Latest reported-7.90%period ending
Latest reported-7.90%period ending
FULC Quarterly SG&A Growth (QoQ) (0.00% → -7.90%)
Latest values, visible window
High-resolution chart · PNG
FULC sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -7.8993% | |
| 11.3371% | |
| -3.7688% | |
| 10.7499% | |
| -2.4432% | |
| -9.2924% | |
| -8.4046% | |
| -17.7906% | |
| 1.8487% | |
| 7.5353% | |
| -6.0737% | |
| -3.5067% | |
| -10.3906% | |
| 13.7216% | |
| 4.3577% | |
| -12.5338% | |
| 3.1509% | |
| 10.8604% | |
| 12.4826% | |
| 29.0651% | |
| 21.5897% | |
| -6.2894% | |
| 10.448% | |
| 3.1657% | |
| 1.6785% | |
| 15.0125% | |
| 25.4416% | |
| 33.2574% | |
| 1.3857% | |
| 8.6575% | |
| 12.5176% | |
| 3.1053% | |
| 18.6528% | |
| 0% |